BioCentury
ARTICLE | Clinical News

Introgen receives STTR grant for cancer

December 28, 2000 8:00 AM UTC

INGN received a $208,000 STTR grant from the National Cancer Institute to develop its AV1Y28 adenoviral vector, which contains a gene for a single chain antibody against Ras proteins. The vector is de...